Galectin Therapeutics (GALT) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,605.00 |
| Dec 31, 2025 | -15,717.00 |
| Sep 30, 2025 | 8,295.00 |
| Jun 30, 2025 | -185,313.00 |
| Mar 31, 2025 | 7,438.00 |
| Dec 31, 2024 | 37,723.00 |
| Sep 30, 2024 | -127,274.00 |
| Jun 30, 2024 | -28,834.00 |
| Mar 31, 2024 | -10,237.00 |
| Dec 31, 2023 | -22,395.00 |
| Sep 30, 2023 | -22,911.00 |
| Jun 30, 2023 | -15,163.00 |
| Mar 31, 2023 | 26,372.00 |
| Dec 31, 2022 | 3,839.00 |
| Sep 30, 2022 | 19,700.00 |
| Jun 30, 2022 | 4,114.00 |
| Mar 31, 2022 | 6,628.00 |
| Dec 31, 2021 | 7,877.00 |
| Sep 30, 2021 | 5,316.00 |
| Jun 30, 2021 | 788.00 |
| Mar 31, 2021 | -1,797.00 |
| Dec 31, 2020 | 13.00 |
| Mar 31, 2020 | 2,147.00 |
| Dec 31, 2019 | 2,487.00 |
| Sep 30, 2019 | 2,375.00 |
| Jun 30, 2019 | 538.00 |
| Mar 31, 2019 | -9,415.00 |
| Dec 31, 2018 | -2,058.00 |
| Sep 30, 2018 | 5,789.00 |
| Jun 30, 2018 | 1,198.00 |
| Mar 31, 2018 | -52,260.00 |
| Dec 31, 2017 | -50,731.00 |
| Sep 30, 2017 | -38,177.00 |
| Jun 30, 2017 | -14,889.00 |
| Mar 31, 2017 | -7,043.00 |
| Dec 31, 2016 | 2,598.00 |
| Sep 30, 2016 | -5,090.00 |